Evidence map›Paper›PMID 32284563›Full record

ArticleNature microbiology2020

Oxysterols provide innate immunity to bacterial infection by mobilizing cell surface accessible cholesterol.

Michael E Abrams, Kristen A Johnson, Sofya S Perelman, Li-Shu Zhang, Shreya Endapally, Katrina B Mar, Bonne M Thompson, Jeffrey G McDonald, John W Schoggins, Arun Radhakrishnan and 1 more

Open access · greenAbstract read
In one paragraph

Article in Nature microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
21.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 144 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. CMPK2 restrictsbioRxiv : the preprint server for biology · 2026
    Article
  7. Visualization of the interaction between sphingomyelin and cholesterol in lipid bilayer membranes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Therapeutic Innovations for Monkeypox Inhibition.International journal of molecular sciences · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Michael E Abrams *Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Kristen A Johnson *Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Sofya S PerelmanDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Li-Shu ZhangDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Shreya EndapallyDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Katrina B MarDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0003-3640-2418
Bonne M ThompsonDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Jeffrey G McDonaldDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
John W SchogginsDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-7944-6800
Arun RadhakrishnanDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA. arun.radhakrishnan@utsouthwestern.edu.ORCID http://orcid.org/0000-0002-7266-7336
Neal M AltoDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA. neal.alto@utsouthwestern.edu.ORCID http://orcid.org/0000-0002-7602-3853
The University of Texas Southwestern Medical Center · USSouthwestern Medical Center · USNew York University · US

Funding

TRANSCRIPTIONAL REGULATION OF LDL RECEPTOR PROMOTERP01HL020948 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI GOLDSTEIN, JOSEPH L · 1985 to 2021
$103.1M
INTEGRATIVE IMMUNOLOGY TRAINING PROGRAMT32AI005284 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Nan Yan · 2003 to 2026
$7.4M
Type III effector regulation of host signal transduction systemsR01AI083359 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI ALTO, NEAL MATHEW · 2009 to 2024
$6.3M
Discovery of antiviral mechanisms in batsDP2AI117922 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI SCHOGGINS, JOHN W. · 2014 to 2016
$2.6M
Type III effector regulation of host GTPase signalingR56AI083359 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI ALTO, NEAL MATHEW · 2014 to 2014
$452k
Howard Hughes Medical InstituteNHLBI NIH HHS P01 HL020948NIAID NIH HHS DP2 AI117922NIAID NIH HHS R01 AI083359NIAID NIH HHS R56 AI083359NIAID NIH HHS T32 AI005284
6 · The paper itself

Abstract

Cholesterol 25-hydroxylase (CH25H) is an interferon-stimulated gene that converts cholesterol to the oxysterol 25-hydroxycholesterol (25HC). Circulating 25HC modulates essential immunological processes including antiviral immunity, inflammasome activation and antibody class switching; and dysregulation of CH25H may contribute to chronic inflammatory disease and cancer. Although 25HC is a potent regulator of cholesterol storage, uptake, efflux and biosynthesis, how these metabolic activities reprogram the immunological state of target cells remains poorly understood. Here, we used recently designed toxin-based biosensors that discriminate between distinct pools of plasma membrane cholesterol to elucidate how 25HC prevents Listeria monocytogenes from traversing the plasma membrane of infected host cells. The 25HC-mediated activation of acyl-CoA:cholesterol acyltransferase (ACAT) triggered rapid internalization of a biochemically defined fraction of cholesterol, termed 'accessible' cholesterol, from the plasma membrane while having little effect on cholesterol in complexes with sphingomyelin. We show that evolutionarily distinct bacterial species, L. monocytogenes and Shigella flexneri, exploit the accessible pool of cholesterol for infection and that acute mobilization of this pool by oxysterols confers immunity to these pathogens. The significance of this signal-mediated membrane remodelling pathway probably extends beyond host defence systems, as several other biologically active oxysterols also mobilize accessible cholesterol through an ACAT-dependent mechanism.

Indexed as

BacteriaBacterial InfectionsCell MembraneCholesterolCytokinesEpithelial CellsHumansImmunity, InnateInterferonsListeriaModels, MolecularMolecular ConformationMolecular StructureOxysterolsShigellaSterol O-AcyltransferaseCholesterolCytokinesInterferonsOxysterolsSterol O-Acyltransferase

Identifiers

PMID32284563
PMCPMC7442315
OpenAlexW3016252712

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.